Global Regenerative Medicine Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 198781
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Regenerative Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Regenerative Medicine size is estimated to be USD 68590 million in 2026 from USD 34710 million in 2020, with a change XX% between 2020 and 2021. The global Regenerative Medicine market size is expected to grow at a CAGR of 18.6% for the next five years.

Market segmentation

Regenerative Medicine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Cell Therapy

Tissue Engineering

Biomaterial

Other

Market segment by Application, can be divided into

Dermatology

Cardiovascular

CNS

Orthopedic

Others

Market segment by players, this report covers

DePuy Synthes

Medtronic

ZimmerBiomet

Stryker

Acelity

MiMedx Group

Organogenesis

UniQure

Cellular Dynamics International

Osiris Therapeutics

Vcanbio

Gamida Cell

Golden Meditech

Cytori

Celgene

Vericel Corporation

Guanhao Biotech

Mesoblast

Stemcell Technologies

Bellicum Pharmaceuticals

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Regenerative Medicine

1.2 Classification of Regenerative Medicine by Type

1.2.1 Overview: Global Regenerative Medicine Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Regenerative Medicine Revenue Market Share by Type in 2020

1.2.3 Cell Therapy

1.2.4 Tissue Engineering

1.2.5 Biomaterial

1.2.6 Other

1.3 Global Regenerative Medicine Market by Application

1.3.1 Overview: Global Regenerative Medicine Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Dermatology

1.3.3 Cardiovascular

1.3.4 CNS

1.3.5 Orthopedic

1.3.6 Others

1.4 Global Regenerative Medicine Market Size & Forecast

1.5 Global Regenerative Medicine Market Size and Forecast by Region

1.5.1 Global Regenerative Medicine Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Regenerative Medicine Market Size by Region, (2016-2021)

1.5.3 North America Regenerative Medicine Market Size and Prospect (2016-2026)

1.5.4 Europe Regenerative Medicine Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Regenerative Medicine Market Size and Prospect (2016-2026)

1.5.6 South America Regenerative Medicine Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Regenerative Medicine Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Regenerative Medicine Market Drivers

1.6.2 Regenerative Medicine Market Restraints

1.6.3 Regenerative Medicine Trends Analysis

2 Company Profiles

2.1 DePuy Synthes

2.1.1 DePuy Synthes Details

2.1.2 DePuy Synthes Major Business

2.1.3 DePuy Synthes Regenerative Medicine Product and Solutions

2.1.4 DePuy Synthes Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 DePuy Synthes Recent Developments and Future Plans

2.2 Medtronic

2.2.1 Medtronic Details

2.2.2 Medtronic Major Business

2.2.3 Medtronic Regenerative Medicine Product and Solutions

2.2.4 Medtronic Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Medtronic Recent Developments and Future Plans

2.3 ZimmerBiomet

2.3.1 ZimmerBiomet Details

2.3.2 ZimmerBiomet Major Business

2.3.3 ZimmerBiomet Regenerative Medicine Product and Solutions

2.3.4 ZimmerBiomet Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 ZimmerBiomet Recent Developments and Future Plans

2.4 Stryker

2.4.1 Stryker Details

2.4.2 Stryker Major Business

2.4.3 Stryker Regenerative Medicine Product and Solutions

2.4.4 Stryker Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Stryker Recent Developments and Future Plans

2.5 Acelity

2.5.1 Acelity Details

2.5.2 Acelity Major Business

2.5.3 Acelity Regenerative Medicine Product and Solutions

2.5.4 Acelity Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Acelity Recent Developments and Future Plans

2.6 MiMedx Group

2.6.1 MiMedx Group Details

2.6.2 MiMedx Group Major Business

2.6.3 MiMedx Group Regenerative Medicine Product and Solutions

2.6.4 MiMedx Group Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 MiMedx Group Recent Developments and Future Plans

2.7 Organogenesis

2.7.1 Organogenesis Details

2.7.2 Organogenesis Major Business

2.7.3 Organogenesis Regenerative Medicine Product and Solutions

2.7.4 Organogenesis Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Organogenesis Recent Developments and Future Plans

2.8 UniQure

2.8.1 UniQure Details

2.8.2 UniQure Major Business

2.8.3 UniQure Regenerative Medicine Product and Solutions

2.8.4 UniQure Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 UniQure Recent Developments and Future Plans

2.9 Cellular Dynamics International

2.9.1 Cellular Dynamics International Details

2.9.2 Cellular Dynamics International Major Business

2.9.3 Cellular Dynamics International Regenerative Medicine Product and Solutions

2.9.4 Cellular Dynamics International Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Cellular Dynamics International Recent Developments and Future Plans

2.10 Osiris Therapeutics

2.10.1 Osiris Therapeutics Details

2.10.2 Osiris Therapeutics Major Business

2.10.3 Osiris Therapeutics Regenerative Medicine Product and Solutions

2.10.4 Osiris Therapeutics Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Osiris Therapeutics Recent Developments and Future Plans

2.11 Vcanbio

2.11.1 Vcanbio Details

2.11.2 Vcanbio Major Business

2.11.3 Vcanbio Regenerative Medicine Product and Solutions

2.11.4 Vcanbio Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Vcanbio Recent Developments and Future Plans

2.12 Gamida Cell

2.12.1 Gamida Cell Details

2.12.2 Gamida Cell Major Business

2.12.3 Gamida Cell Regenerative Medicine Product and Solutions

2.12.4 Gamida Cell Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Gamida Cell Recent Developments and Future Plans

2.13 Golden Meditech

2.13.1 Golden Meditech Details

2.13.2 Golden Meditech Major Business

2.13.3 Golden Meditech Regenerative Medicine Product and Solutions

2.13.4 Golden Meditech Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Golden Meditech Recent Developments and Future Plans

2.14 Cytori

2.14.1 Cytori Details

2.14.2 Cytori Major Business

2.14.3 Cytori Regenerative Medicine Product and Solutions

2.14.4 Cytori Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Cytori Recent Developments and Future Plans

2.15 Celgene

2.15.1 Celgene Details

2.15.2 Celgene Major Business

2.15.3 Celgene Regenerative Medicine Product and Solutions

2.15.4 Celgene Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Celgene Recent Developments and Future Plans

2.16 Vericel Corporation

2.16.1 Vericel Corporation Details

2.16.2 Vericel Corporation Major Business

2.16.3 Vericel Corporation Regenerative Medicine Product and Solutions

2.16.4 Vericel Corporation Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 Vericel Corporation Recent Developments and Future Plans

2.17 Guanhao Biotech

2.17.1 Guanhao Biotech Details

2.17.2 Guanhao Biotech Major Business

2.17.3 Guanhao Biotech Regenerative Medicine Product and Solutions

2.17.4 Guanhao Biotech Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 Guanhao Biotech Recent Developments and Future Plans

2.18 Mesoblast

2.18.1 Mesoblast Details

2.18.2 Mesoblast Major Business

2.18.3 Mesoblast Regenerative Medicine Product and Solutions

2.18.4 Mesoblast Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.18.5 Mesoblast Recent Developments and Future Plans

2.19 Stemcell Technologies

2.19.1 Stemcell Technologies Details

2.19.2 Stemcell Technologies Major Business

2.19.3 Stemcell Technologies Regenerative Medicine Product and Solutions

2.19.4 Stemcell Technologies Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.19.5 Stemcell Technologies Recent Developments and Future Plans

2.20 Bellicum Pharmaceuticals

2.20.1 Bellicum Pharmaceuticals Details

2.20.2 Bellicum Pharmaceuticals Major Business

2.20.3 Bellicum Pharmaceuticals Regenerative Medicine Product and Solutions

2.20.4 Bellicum Pharmaceuticals Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.20.5 Bellicum Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Regenerative Medicine Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Regenerative Medicine Players Market Share

3.2.2 Top 10 Regenerative Medicine Players Market Share

3.2.3 Market Competition Trend

3.3 Regenerative Medicine Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Regenerative Medicine Revenue and Market Share by Type (2016-2021)

4.2 Global Regenerative Medicine Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Regenerative Medicine Revenue Market Share by Application (2016-2021)

5.2 Regenerative Medicine Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Regenerative Medicine Revenue by Type (2016-2026)

6.2 North America Regenerative Medicine Revenue by Application (2016-2026)

6.3 North America Regenerative Medicine Market Size by Country

6.3.1 North America Regenerative Medicine Revenue by Country (2016-2026)

6.3.2 United States Regenerative Medicine Market Size and Forecast (2016-2026)

6.3.3 Canada Regenerative Medicine Market Size and Forecast (2016-2026)

6.3.4 Mexico Regenerative Medicine Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Regenerative Medicine Revenue by Type (2016-2026)

7.2 Europe Regenerative Medicine Revenue by Application (2016-2026)

7.3 Europe Regenerative Medicine Market Size by Country

7.3.1 Europe Regenerative Medicine Revenue by Country (2016-2026)

7.3.2 Germany Regenerative Medicine Market Size and Forecast (2016-2026)

7.3.3 France Regenerative Medicine Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Regenerative Medicine Market Size and Forecast (2016-2026)

7.3.5 Russia Regenerative Medicine Market Size and Forecast (2016-2026)

7.3.6 Italy Regenerative Medicine Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Regenerative Medicine Revenue by Type (2016-2026)

8.2 Asia-Pacific Regenerative Medicine Revenue by Application (2016-2026)

8.3 Asia-Pacific Regenerative Medicine Market Size by Region

8.3.1 Asia-Pacific Regenerative Medicine Revenue by Region (2016-2026)

8.3.2 China Regenerative Medicine Market Size and Forecast (2016-2026)

8.3.3 Japan Regenerative Medicine Market Size and Forecast (2016-2026)

8.3.4 South Korea Regenerative Medicine Market Size and Forecast (2016-2026)

8.3.5 India Regenerative Medicine Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Regenerative Medicine Market Size and Forecast (2016-2026)

8.3.7 Australia Regenerative Medicine Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Regenerative Medicine Revenue by Type (2016-2026)

9.2 South America Regenerative Medicine Revenue by Application (2016-2026)

9.3 South America Regenerative Medicine Market Size by Country

9.3.1 South America Regenerative Medicine Revenue by Country (2016-2026)

9.3.2 Brazil Regenerative Medicine Market Size and Forecast (2016-2026)

9.3.3 Argentina Regenerative Medicine Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Regenerative Medicine Revenue by Type (2016-2026)

10.2 Middle East & Africa Regenerative Medicine Revenue by Application (2016-2026)

10.3 Middle East & Africa Regenerative Medicine Market Size by Country

10.3.1 Middle East & Africa Regenerative Medicine Revenue by Country (2016-2026)

10.3.2 Turkey Regenerative Medicine Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Regenerative Medicine Market Size and Forecast (2016-2026)

10.3.4 UAE Regenerative Medicine Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Regenerative Medicine Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Regenerative Medicine Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Regenerative Medicine Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Regenerative Medicine Revenue (USD Million) by Region (2016-2021)

Table 5. Global Regenerative Medicine Revenue Market Share by Region (2021-2026)

Table 6. DePuy Synthes Corporate Information, Head Office, and Major Competitors

Table 7. DePuy Synthes Major Business

Table 8. DePuy Synthes Regenerative Medicine Product and Solutions

Table 9. DePuy Synthes Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Medtronic Corporate Information, Head Office, and Major Competitors

Table 11. Medtronic Major Business

Table 12. Medtronic Regenerative Medicine Product and Solutions

Table 13. Medtronic Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. ZimmerBiomet Corporate Information, Head Office, and Major Competitors

Table 15. ZimmerBiomet Major Business

Table 16. ZimmerBiomet Regenerative Medicine Product and Solutions

Table 17. ZimmerBiomet Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Stryker Corporate Information, Head Office, and Major Competitors

Table 19. Stryker Major Business

Table 20. Stryker Regenerative Medicine Product and Solutions

Table 21. Stryker Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Acelity Corporate Information, Head Office, and Major Competitors

Table 23. Acelity Major Business

Table 24. Acelity Regenerative Medicine Product and Solutions

Table 25. Acelity Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. MiMedx Group Corporate Information, Head Office, and Major Competitors

Table 27. MiMedx Group Major Business

Table 28. MiMedx Group Regenerative Medicine Product and Solutions

Table 29. MiMedx Group Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Organogenesis Corporate Information, Head Office, and Major Competitors

Table 31. Organogenesis Major Business

Table 32. Organogenesis Regenerative Medicine Product and Solutions

Table 33. Organogenesis Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. UniQure Corporate Information, Head Office, and Major Competitors

Table 35. UniQure Major Business

Table 36. UniQure Regenerative Medicine Product and Solutions

Table 37. UniQure Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Cellular Dynamics International Corporate Information, Head Office, and Major Competitors

Table 39. Cellular Dynamics International Major Business

Table 40. Cellular Dynamics International Regenerative Medicine Product and Solutions

Table 41. Cellular Dynamics International Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Osiris Therapeutics Corporate Information, Head Office, and Major Competitors

Table 43. Osiris Therapeutics Major Business

Table 44. Osiris Therapeutics Regenerative Medicine Product and Solutions

Table 45. Osiris Therapeutics Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Vcanbio Corporate Information, Head Office, and Major Competitors

Table 47. Vcanbio Major Business

Table 48. Vcanbio Regenerative Medicine Product and Solutions

Table 49. Vcanbio Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Gamida Cell Corporate Information, Head Office, and Major Competitors

Table 51. Gamida Cell Major Business

Table 52. Gamida Cell Regenerative Medicine Product and Solutions

Table 53. Gamida Cell Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Golden Meditech Corporate Information, Head Office, and Major Competitors

Table 55. Golden Meditech Major Business

Table 56. Golden Meditech Regenerative Medicine Product and Solutions

Table 57. Golden Meditech Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Cytori Corporate Information, Head Office, and Major Competitors

Table 59. Cytori Major Business

Table 60. Cytori Regenerative Medicine Product and Solutions

Table 61. Cytori Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Celgene Corporate Information, Head Office, and Major Competitors

Table 63. Celgene Major Business

Table 64. Celgene Regenerative Medicine Product and Solutions

Table 65. Celgene Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Vericel Corporation Corporate Information, Head Office, and Major Competitors

Table 67. Vericel Corporation Major Business

Table 68. Vericel Corporation Regenerative Medicine Product and Solutions

Table 69. Vericel Corporation Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. Guanhao Biotech Corporate Information, Head Office, and Major Competitors

Table 71. Guanhao Biotech Major Business

Table 72. Guanhao Biotech Regenerative Medicine Product and Solutions

Table 73. Guanhao Biotech Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. Mesoblast Corporate Information, Head Office, and Major Competitors

Table 75. Mesoblast Major Business

Table 76. Mesoblast Regenerative Medicine Product and Solutions

Table 77. Mesoblast Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 78. Stemcell Technologies Corporate Information, Head Office, and Major Competitors

Table 79. Stemcell Technologies Major Business

Table 80. Stemcell Technologies Regenerative Medicine Product and Solutions

Table 81. Stemcell Technologies Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 82. Bellicum Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 83. Bellicum Pharmaceuticals Major Business

Table 84. Bellicum Pharmaceuticals Regenerative Medicine Product and Solutions

Table 85. Bellicum Pharmaceuticals Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 86. Global Regenerative Medicine Revenue (USD Million) by Players (2019-2021)

Table 87. Global Regenerative Medicine Revenue Share by Players (2019-2021)

Table 88. Breakdown of Regenerative Medicine by Company Type (Tier 1, Tier 2 and Tier 3)

Table 89. Regenerative Medicine Players Head Office, Products and Services Provided

Table 90. Regenerative Medicine Mergers & Acquisitions in the Past Five Years

Table 91. Regenerative Medicine New Entrants and Expansion Plans

Table 92. Global Regenerative Medicine Revenue (USD Million) by Type (2016-2021)

Table 93. Global Regenerative Medicine Revenue Share by Type (2016-2021)

Table 94. Global Regenerative Medicine Revenue Forecast by Type (2021-2026)

Table 95. Global Regenerative Medicine Revenue by Application (2016-2021)

Table 96. Global Regenerative Medicine Revenue Forecast by Application (2021-2026)

Table 97. North America Regenerative Medicine Revenue by Type (2016-2021) & (USD Million)

Table 98. North America Regenerative Medicine Revenue by Type (2021-2026) & (USD Million)

Table 99. North America Regenerative Medicine Revenue by Application (2016-2021) & (USD Million)

Table 100. North America Regenerative Medicine Revenue by Application (2021-2026) & (USD Million)

Table 101. North America Regenerative Medicine Revenue by Country (2016-2021) & (USD Million)

Table 102. North America Regenerative Medicine Revenue by Country (2021-2026) & (USD Million)

Table 103. Europe Regenerative Medicine Revenue by Type (2016-2021) & (USD Million)

Table 104. Europe Regenerative Medicine Revenue by Type (2021-2026) & (USD Million)

Table 105. Europe Regenerative Medicine Revenue by Application (2016-2021) & (USD Million)

Table 106. Europe Regenerative Medicine Revenue by Application (2021-2026) & (USD Million)

Table 107. Europe Regenerative Medicine Revenue by Country (2016-2021) & (USD Million)

Table 108. Europe Regenerative Medicine Revenue by Country (2021-2026) & (USD Million)

Table 109. Asia-Pacific Regenerative Medicine Revenue by Type (2016-2021) & (USD Million)

Table 110. Asia-Pacific Regenerative Medicine Revenue by Type (2021-2026) & (USD Million)

Table 111. Asia-Pacific Regenerative Medicine Revenue by Application (2016-2021) & (USD Million)

Table 112. Asia-Pacific Regenerative Medicine Revenue by Application (2021-2026) & (USD Million)

Table 113. Asia-Pacific Regenerative Medicine Revenue by Region (2016-2021) & (USD Million)

Table 114. Asia-Pacific Regenerative Medicine Revenue by Region (2021-2026) & (USD Million)

Table 115. South America Regenerative Medicine Revenue by Type (2016-2021) & (USD Million)

Table 116. South America Regenerative Medicine Revenue by Type (2021-2026) & (USD Million)

Table 117. South America Regenerative Medicine Revenue by Application (2016-2021) & (USD Million)

Table 118. South America Regenerative Medicine Revenue by Application (2021-2026) & (USD Million)

Table 119. South America Regenerative Medicine Revenue by Country (2016-2021) & (USD Million)

Table 120. South America Regenerative Medicine Revenue by Country (2021-2026) & (USD Million)

Table 121. Middle East & Africa Regenerative Medicine Revenue by Type (2016-2021) & (USD Million)

Table 122. Middle East & Africa Regenerative Medicine Revenue by Type (2021-2026) & (USD Million)

Table 123. Middle East & Africa Regenerative Medicine Revenue by Application (2016-2021) & (USD Million)

Table 124. Middle East & Africa Regenerative Medicine Revenue by Application (2021-2026) & (USD Million)

Table 125. Middle East & Africa Regenerative Medicine Revenue by Country (2016-2021) & (USD Million)

Table 126. Middle East & Africa Regenerative Medicine Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Regenerative Medicine Picture

Figure 2. Global Regenerative Medicine Revenue Market Share by Type in 2020

Figure 3. Cell Therapy

Figure 4. Tissue Engineering

Figure 5. Biomaterial

Figure 6. Other

Figure 7. Regenerative Medicine Revenue Market Share by Application in 2020

Figure 8. Dermatology Picture

Figure 9. Cardiovascular Picture

Figure 10. CNS Picture

Figure 11. Orthopedic Picture

Figure 12. Others Picture

Figure 13. Global Regenerative Medicine Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 14. Global Regenerative Medicine Revenue and Forecast (2016-2026) & (USD Million)

Figure 15. Global Regenerative Medicine Revenue Market Share by Region (2016-2026)

Figure 16. Global Regenerative Medicine Revenue Market Share by Region in 2020

Figure 17. North America Regenerative Medicine Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Europe Regenerative Medicine Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Asia-Pacific Regenerative Medicine Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. South America Regenerative Medicine Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Middle East and Africa Regenerative Medicine Revenue (USD Million) and Growth Rate (2016-2026)

Figure 22. Regenerative Medicine Market Drivers

Figure 23. Regenerative Medicine Market Restraints

Figure 24. Regenerative Medicine Market Trends

Figure 25. DePuy Synthes Recent Developments and Future Plans

Figure 26. Medtronic Recent Developments and Future Plans

Figure 27. ZimmerBiomet Recent Developments and Future Plans

Figure 28. Stryker Recent Developments and Future Plans

Figure 29. Acelity Recent Developments and Future Plans

Figure 30. MiMedx Group Recent Developments and Future Plans

Figure 31. Organogenesis Recent Developments and Future Plans

Figure 32. UniQure Recent Developments and Future Plans

Figure 33. Cellular Dynamics International Recent Developments and Future Plans

Figure 34. Osiris Therapeutics Recent Developments and Future Plans

Figure 35. Vcanbio Recent Developments and Future Plans

Figure 36. Gamida Cell Recent Developments and Future Plans

Figure 37. Golden Meditech Recent Developments and Future Plans

Figure 38. Cytori Recent Developments and Future Plans

Figure 39. Celgene Recent Developments and Future Plans

Figure 40. Vericel Corporation Recent Developments and Future Plans

Figure 41. Guanhao Biotech Recent Developments and Future Plans

Figure 42. Mesoblast Recent Developments and Future Plans

Figure 43. Stemcell Technologies Recent Developments and Future Plans

Figure 44. Bellicum Pharmaceuticals Recent Developments and Future Plans

Figure 45. Global Regenerative Medicine Revenue Share by Players in 2020

Figure 46. Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 47. Global Top 3 Players Regenerative Medicine Revenue Market Share in 2020

Figure 48. Global Top 10 Players Regenerative Medicine Revenue Market Share in 2020

Figure 49. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 50. Global Regenerative Medicine Revenue Share by Type in 2020

Figure 51. Global Regenerative Medicine Market Share Forecast by Type (2021-2026)

Figure 52. Global Regenerative Medicine Revenue Share by Application in 2020

Figure 53. Global Regenerative Medicine Market Share Forecast by Application (2021-2026)

Figure 54. North America Regenerative Medicine Sales Market Share by Type (2016-2026)

Figure 55. North America Regenerative Medicine Sales Market Share by Application (2016-2026)

Figure 56. North America Regenerative Medicine Revenue Market Share by Country (2016-2026)

Figure 57. United States Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Canada Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Mexico Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Europe Regenerative Medicine Sales Market Share by Type (2016-2026)

Figure 61. Europe Regenerative Medicine Sales Market Share by Application (2016-2026)

Figure 62. Europe Regenerative Medicine Revenue Market Share by Country (2016-2026)

Figure 63. Germany Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. France Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. United Kingdom Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Russia Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Italy Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Asia-Pacific Regenerative Medicine Sales Market Share by Type (2016-2026)

Figure 69. Asia-Pacific Regenerative Medicine Sales Market Share by Application (2016-2026)

Figure 70. Asia-Pacific Regenerative Medicine Revenue Market Share by Region (2016-2026)

Figure 71. China Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Japan Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. South Korea Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. India Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Southeast Asia Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Australia Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. South America Regenerative Medicine Sales Market Share by Type (2016-2026)

Figure 78. South America Regenerative Medicine Sales Market Share by Application (2016-2026)

Figure 79. South America Regenerative Medicine Revenue Market Share by Country (2016-2026)

Figure 80. Brazil Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 81. Argentina Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. Middle East and Africa Regenerative Medicine Sales Market Share by Type (2016-2026)

Figure 83. Middle East and Africa Regenerative Medicine Sales Market Share by Application (2016-2026)

Figure 84. Middle East and Africa Regenerative Medicine Revenue Market Share by Country (2016-2026)

Figure 85. Turkey Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 86. Saudi Arabia Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 87. UAE Regenerative Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 88. Methodology

Figure 89. Research Process and Data Source